Overview

A Study to Evaluate the Efficacy and Safety of Clevudine and Peg-interferon in Sequence Compared With Clevudine Alone in the Patients With HBeAg(+) Chronic Hepatitis B or Clevudine and Peg-interferon Sequential Treatment in Patients With Chronic Hep

Status:
Completed

Trial end date:
2014-05-01

Target enrollment:

Participant gender:

Summary

A study to evaluate the efficacy and safety of clevudine and peg-interferon in sequence compared with clevudine alone in the patients with HBeAg(+) chronic Hepatitis B or clevudine and peg-interferon sequential treatment in patients with chronic Hepatitis B who have HBeAg(+)

Phase:

Phase 4

Details

Lead Sponsor:

Bukwang Pharmaceutical

Treatments:

Clevudine
Interferons